
Pittsburgh Life Sciences Greenhouse
Investments
123Portfolio Exits
9Funds
2Partners & Customers
2About Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse (PLSG) was designed to be the Economic Development engine behind life sciences in Western Pennsylvania. Established in 2002 by funding from major foundations and the state of Pennsylvania, its charter was to leverage the intellectual capital of Pittsburgh's world-class universities and medical facilities to establish life sciences companies. PLSG has been a resource center; supporting life sciences start-ups, recruiting star university researchers and seasoned life science executives to the region. All with the goal of speeding up the routing of product from technology to commercialization.
Pittsburgh Life Sciences Greenhouse Headquarter Location
2425 Sidney Street
Pittsburgh, Pennsylvania, 15203,
United States
412-770-1628
Pittsburgh Life Sciences Greenhouse Web Traffic
Pittsburgh Life Sciences Greenhouse Rank
Latest Pittsburgh Life Sciences Greenhouse News
Oct 25, 2021
Cernostics was originally supported by PLSG seed funding News provided by Share this article Share this article PITTSBURGH, Oct. 25, 2021 /PRNewswire/ -- Pittsburgh Life Science Greenhouse (PLSG) is proud to share that one of its portfolio companies, Cernostics, Inc., is being acquired by Castle Biosciences (Nasdaq: CSTL ). Cernostics specializes in spatial biology and artificial intelligence-driven image analysis of tissue biopsies. Its TissueCypher® Barrett's Esophagus Assay is the first precision medicine test designed to predict future development of high-grade dysplasia (HGD) and/or esophageal cancer in patients with Barrett's esophagus (BE). Under the terms of the definitive agreement, Cernostics will become a wholly owned subsidiary of Castle Biosciences. At closing, Castle will pay $30 million in initial consideration to Cernostics security holders, which may consist entirely of cash or $20 million in cash and $10 million in common stock of Castle, at Castle's sole discretion. The purchase price is subject to customary working capital and other adjustments. Further, up to an additional $50 million in cash and/or common stock, at Castle's sole discretion, is payable in connection with the achievement of certain milestones based on 2022 performance. The transaction is expected to close prior to year-end 2021. "We are excited about joining forces with Castle, a leader in the precision diagnostics space with a strong history of commercial success," said Mike Hoerres, Chief Executive Officer of Cernostics. "We are grateful for the PLSG's financial and executive management support of our technology. Cernostics could not have gotten to this point without the type of economic development support the PLSG provides." "PLSG identified early on the value of the assay and worked diligently to provide the support needed for success," said PLSG CEO Diana Cugliari. "We are so excited that this precision diagnostic will now reach more patients and bring early detection to prevent suffering from esophageal cancer. " The influx of capital PLSG expects to receive from Cernostics' acquisition will be reinvested back into the region to support the efforts of other life sciences startup companies, simultaneously cultivating scientific breakthroughs, strengthening our region's economy, and creating jobs. "The success of Cernostics once again underscores the mission of PLSG – perpetuating the cycle of life sciences startup companies from inception to commercialization and leveraging that success to grow the next generation of life sciences companies to enrich our region's economy as well as advance scientific discovery. This is another great economic development success story for the region and for the Commonwealth of Pennsylvania, who have steadfastly supported our efforts," said Ms. Cugliari. Cernostics' executive management team and other staff who are based in Pittsburgh are expected to stay with the company, and both laboratory and operations will remain in Pittsburgh. About Pittsburgh Life Sciences Greenhouse The Pittsburgh Life Sciences Greenhouse (PLSG) is a comprehensive life sciences economic development organization. We are dedicated to advancing life sciences in western Pennsylvania by building on the region's strengths in research, clinical care and life sciences entrepreneurship. We serve our community by providing knowledge, connection and capital to help companies grow, create jobs and improve the health of all humanity. For more information, please visit www.plsg.com . About Cernostics and TissueCypher® Barrett's Esophagus Assay Cernostics applies spatial biology and biologically-aware AI and machine learning (ML) to tissue diagnostics, delivering precision diagnostic testing to patients and gastroenterologists. This technology and platform are the core of the TissueCypher® Barrett's Esophagus Assay, the world's first precision medicine test that predicts future development of high-grade dysplasia (HGD) and/or esophageal cancer in patients with Barrett's esophagus (BE). TissueCypher is indicated for BE patients with confirmed intestinal metaplasia graded non-dysplastic (ND), indefinite for dysplasia (IND) or low-grade dysplasia (LGD). TissueCypher is a proprietary Laboratory Developed Test (LDT) with its own unique CPT PLA code (0108U), available only from Cernostics' CLIA-certified pathology laboratory. TissueCypher has been on the Medicare Clinical Laboratory Fee Schedule since January 2021. SOURCE Pittsburgh Life Sciences Greenhouse Related Links
Pittsburgh Life Sciences Greenhouse Investments
123 Investments
Pittsburgh Life Sciences Greenhouse has made 123 investments. Their latest investment was in MindTrace as part of their Incubator/Accelerator - III on June 6, 2021.
Pittsburgh Life Sciences Greenhouse Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
6/3/2021 | Incubator/Accelerator - III | MindTrace | $0.5M | Yes | 2 | |
2/10/2021 | Unattributed | Piestro | $0.1M | Yes | 1 | |
2/9/2018 | Seed VC | Clinical Platform | $0.05M | Yes | 2 | |
5/8/2017 | Option/Warrant | |||||
3/31/2017 | Unattributed VC |
Date | 6/3/2021 | 2/10/2021 | 2/9/2018 | 5/8/2017 | 3/31/2017 |
---|---|---|---|---|---|
Round | Incubator/Accelerator - III | Unattributed | Seed VC | Option/Warrant | Unattributed VC |
Company | MindTrace | Piestro | Clinical Platform | ||
Amount | $0.5M | $0.1M | $0.05M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 2 | 1 | 2 |
Pittsburgh Life Sciences Greenhouse Portfolio Exits
9 Portfolio Exits
Pittsburgh Life Sciences Greenhouse has 9 portfolio exits. Their latest portfolio exit was ALung Technologies on May 05, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
5/5/2022 | Acquired | 2 | |||
Date | 5/5/2022 | ||||
---|---|---|---|---|---|
Exit | Acquired | ||||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 |
Pittsburgh Life Sciences Greenhouse Fund History
2 Fund Histories
Pittsburgh Life Sciences Greenhouse has 2 funds, including Accelerator Fund II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
5/1/2017 | Accelerator Fund II | $5.2M | 2 | ||
12/31/2011 | PLSG Accelerator Fund LLC |
Closing Date | 5/1/2017 | 12/31/2011 |
---|---|---|
Fund | Accelerator Fund II | PLSG Accelerator Fund LLC |
Fund Type | ||
Status | ||
Amount | $5.2M | |
Sources | 2 |
Pittsburgh Life Sciences Greenhouse Partners & Customers
2 Partners and customers
Pittsburgh Life Sciences Greenhouse has 2 strategic partners and customers. Pittsburgh Life Sciences Greenhouse recently partnered with LifeX Ventures on June 6, 2021.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
6/30/2021 | Partner | United States | 1 | ||
8/16/2009 | Partner |
Date | 6/30/2021 | 8/16/2009 |
---|---|---|
Type | Partner | Partner |
Business Partner | ||
Country | United States | |
News Snippet | ||
Sources | 1 |
Pittsburgh Life Sciences Greenhouse Team
6 Team Members
Pittsburgh Life Sciences Greenhouse has 6 team members, including former Chief Executive Officer, President, James F Jordan.
Name | Work History | Title | Status |
---|---|---|---|
James F Jordan | Chief Executive Officer, President | Former | |
Doros Platika | Chief Executive Officer, President | Former | |
Donald F Smith | Chief Executive Officer | Former | |
Dennis Yablonsky | President | Former | |
Philip G Petraglia | Chief Financial Officer | Former |
Name | James F Jordan | Doros Platika | Donald F Smith | Dennis Yablonsky | Philip G Petraglia |
---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer, President | Chief Executive Officer, President | Chief Executive Officer | President | Chief Financial Officer |
Status | Former | Former | Former | Former | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.